---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-000613"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2026-01-06T23:59:59+00:00"
generated_at: "2026-05-16T11:36:26.036828+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Oncotelic completes Tranche 3 of unit offering, raising $1.1M from 22 investors

## Summary
- Issued 44 units under final Tranche 3; each unit includes a $25,000 principal, 12% 2-year convertible note.
- Each note convertible into 250,000 shares of Oncotelic at $0.10 or 25,000 EdgePoint shares at $1.00.
- Each unit includes 250,000 warrants to purchase Oncotelic stock at $0.12 or EdgePoint warrants at $1.25.
- Prior 2023 PPM notes settled; existing warrants extended to two years from final closing.
- Registration Rights Agreement executed for shares and warrants issued in the financing.

## SEC filing metadata
- accession: 0001493152-26-000613
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2026-01-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315226000613/0001493152-26-000613-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315226000613/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-000613
- JSON: https://secwatch.observer/filing/0001493152-26-000613.json
- Plain text: https://secwatch.observer/filing/0001493152-26-000613.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.